Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and future - Wintrich, Jan; Kindermann, Ingrid; Ukena, Christian; Selejan, Simina; Werner, Christian; Maack, Christoph; Laufs, Ulrich; Tschöpe, Carsten; Anker, Stefan D.; Lam, Carolyn S. P.; Voors, Adriaan A.; Böhm, Michael (Clinical research in cardiology, 2020)
Keywords: Aminobutyrates - administration & dosage; Aminobutyrates - pharmacology; Angiotensin Receptor Antagonists - administration & dosage; Angiotensin Receptor Antagonists - pharmacology; Animals; Biomarkers; Biphenyl Compounds - administration & dosage; Biphenyl Compounds - pharmacology; Cardiology; Clinical trials; Congestive heart failure; Drug Combinations; Ejection fraction; Fibrosis; Heart failure; Heart Failure - diagnosis; Heart Failure - physiopathology; Heart Failure - therapy; Hospitalization - statistics & numerical data; Humans; Medicine; Medicine & Public Health; Na+/glucose cotransporter; Patients; Phenotypes; Randomized Controlled Trials as Topic; Review; Stroke Volume - physiology; Subgroups; Valsartan - administration & dosage; Valsartan - pharmacology; Heart failure; Pharmacotherapy in HFpEF; Device therapy; Preserved ejection fraction; LCZ696